Key Findings from the NATALEE Trial : vimarsana.com

Stephanie Graff, MD, and Rachel Layman, MD, discuss the design and results of the NATALEE trial, which evaluated adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer.

Related Keywords

Mammaprint Oncotype , Stephanie Graff , , Breast Cancer , Clinical Case , Hr , High Risk Factor , Grade , Oncology , Recurrence , Lymph Nodes , Natalee Trial , Cdk4 6 Inhibitors , Ribociclib , Adjuvant Endocrine Therapy ,